They reported significant improvements in lung function, reduced collagen deposition, and increased MMP-9 expression in the high-dose group, whereas the low-dose group exhibited only modest effects, highlighting the benefits of higher doses for established pulmonary fibrosis. Here, MMP9 is linked to pulmonary fibrosis.